BioLargo Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
BioLargo Stock Forecast and Price Target
BioLargo's stock price reaches the average target of $0.35 by 2025 as expected recently by notable experts, there would be a potential downside of approximately 0% from the last closing price in April, 2024. This possible increase is based on a high estimate of $0.35 and a low estimate of $0.35. If you're looking to buy BioLargo stock, you may also want to check out its rivals.
0.00% Upside
BioLargo Fair Value Forecast for 2023 - 2025 - 2030
BioLargo's Price has grown in the last year, jumping from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach $0.38 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$161.29 | Buy/Sell | $166.80 | 7.26% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$146.14 | Buy/Sell | $174.55 | 16.33% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
177.62€ | Buy/Sell | 178.14€ | 10.07% |
| ECL Stock Forecast | Ecolab | Hold |
18
|
$221.10 | Buy/Sell | $205.36 | 4.48% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£44.23 | Buy/Sell | £66.68 | 22.09% |
BioLargo Revenue Forecast for 2023 - 2025 - 2030
BioLargo's Revenue has grown in the last two years, jumping from $2.43M to $5.88M – an increase of 141.98%. In the next year, analysts predict that Revenue will reach $17.49M – an increase of 197.45%. For the next seven years, the forecast is for Revenue to grow by 188.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XYL Stock Forecast | Xylem | Outperform |
16
|
$132.40 | Buy/Sell | $129.21 | 7.25% |
| STE Stock Forecast | STERIS | Outperform |
13
|
$203.90 | Buy/Sell | $238.33 | 18.20% |
| CLX Stock Forecast | Clorox Co-The | Hold |
16
|
$146.48 | Buy/Sell | $154.18 | 5.82% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PNR Stock Forecast | Pentair | Outperform |
11
|
$79.96 | Buy/Sell | $81.18 | 13.18% |
| SQM Stock Forecast | Sociedad Química y Minera de ... | Outperform |
17
|
$44.14 | Buy/Sell | $74.26 | 58.59% |
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.81 | Buy/Sell | £16.09 | 67.28% |
BioLargo EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, BioLargo's EBITDA has decreased from $-7.41M to $-5.09M – a 31.31% drop. For the following year, the 1 analysts predict that BioLargo's EBITDA will drop by 78.19%, reaching $-1.11M. In 2030, the professionals' prediction is that BLGO's EBITDA will decrease by 183.23%, reaching $4.24M.
BioLargo EBIT Forecast for 2023 - 2025 - 2030
BioLargo's EBIT has decreased by 31.33% In the last two years, from $-7.47M to $-5.13M. In the following year, the 1 analysts surveyed believe that BioLargo's EBIT will decrease by 70.96%, reaching $-1.49M. According to professionals, by 2030, BioLargo's EBIT will have decreased by 131.33%, falling down to $1.61M.
BioLargo EPS Price Prediction Forecast for 2023 - 2025 - 2030
BioLargo's EPS has grown in the last year, jumping from $-0.02 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach $-0.01 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)